Compare TARA & ZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TARA | ZH |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.1M | 242.4M |
| IPO Year | 2014 | 2021 |
| Metric | TARA | ZH |
|---|---|---|
| Price | $3.89 | $2.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $24.40 | N/A |
| AVG Volume (30 Days) | ★ 313.1K | 294.1K |
| Earning Date | 05-01-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,948,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $20.74 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.02 | $2.57 |
| 52 Week High | $7.82 | $5.55 |
| Indicator | TARA | ZH |
|---|---|---|
| Relative Strength Index (RSI) | 39.12 | 40.89 |
| Support Level | $3.73 | $2.57 |
| Resistance Level | $4.17 | $3.37 |
| Average True Range (ATR) | 0.14 | 0.13 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 17.91 | 36.76 |
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
Zhihu Inc is engaged in the operation of one online content community which monetizes through paid membership services, marketing services and other services in the People's Republic of China. It is an online content community where people come to find solutions, make decisions, seek inspiration, and have fun. Its community supports discussions ranging from everyday consumer decisions, such as purchasing products or planning travel, to more specialized areas on professional knowledge, technological developments including artificial intelligence and academic topics. It operates in single segment and its revenues are derived from within the PRC.